Docket
118th Congress · HOUSE BILLBILL

H.R. 8267 — Old Drugs, New Cures Act

“To amend titles XVIII and XIX of the Social Security Act to provide that priority research drugs shall not be treated as line extensions of existing drugs for purposes of calculating manufacturer rebates under the Medicare and Medicaid programs, and for other purposes.”

Health
Introduced May 7, 2024
Last action Dec 17, 2024
Pipeline · Bill → Law
Step 1
Introduced
May 7, 2024
Step 2
Referred
Dec 17, 2024
E&C · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House
Timeline · 5 actions
Dec 17, 2024
Referred to the Subcommittee on Health.
May 10, 2024
Referred to the Subcommittee on Health.
May 7, 2024
Introduced in House
May 7, 2024
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 7, 2024
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.